Catalyst Funds Management Pty LTD Vigil Neuroscience, Inc. Transaction History
Catalyst Funds Management Pty LTD
- $455 Billion
- Q3 2024
A detailed history of Catalyst Funds Management Pty LTD transactions in Vigil Neuroscience, Inc. stock. As of the latest transaction made, Catalyst Funds Management Pty LTD holds 4,100 shares of VIGL stock, worth $13,120. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,100Holding current value
$13,120% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding VIGL
# of Institutions
55Shares Held
28MCall Options Held
0Put Options Held
0-
Atlas Venture Life Science Advisors, LLC5.84MShares$18.7 Million2.45% of portfolio
-
Northpond Ventures, LLC4.21MShares$13.5 Million51.65% of portfolio
-
Siren, L.L.C. New York, NY1.99MShares$6.37 Million0.34% of portfolio
-
Bvf Inc San Francisco, CA1.81MShares$5.8 Million0.2% of portfolio
-
Sphera Funds Management Ltd. Tel Aviv, L31.65MShares$5.27 Million1.03% of portfolio
About Vigil Neuroscience, Inc.
- Ticker VIGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,268,600
- Market Cap $90.5M
- Description
- Vigil Neuroscience, Inc., a microglia-focused company, engages in the development of disease-modifying therapeutics for patients, caregivers, and families affected by rare and common neurodegenerative diseases. Its lead product candidate is VGL101, a fully human monoclonal antibody (mAb) that is designed to activate triggering receptor expressed...